Voloridge Investment Management
MIRM icon

Voloridge Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Voloridge Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-104,099
Closed -$9.62M – 980
2026
Q1 		$9.62M Sell
104,099
-193,851
-65% -$18.2M 0.04% 516
2025
Q4 		$23.5M Sell
297,950
-91,624
-24% -$6.58M 0.08% 317
2025
Q3 		$28.6M Buy
389,574
+371,999
+2,117% +$23.6M 0.1% 251
2025
Q2 		$894K Sell
17,575
-57,430
-77% -$2.56M ﹤0.01% 1040
2025
Q1 		$3.38M Sell
75,005
-96,532
-56% -$4.55M 0.01% 877
2024
Q4 		$7.09M Sell
171,537
-85,242
-33% -$3.55M 0.03% 675
2024
Q3 		$10M Buy
+256,779
New +$10.2M 0.04% 587
2024
Q1 		– Sell
-70,441
Closed -$2.08M – 1280
2023
Q4 		$2.08M Sell
70,441
-173,550
-71% -$5.25M 0.01% 822
2023
Q3 		$7.71M Buy
+243,991
New +$6.68M 0.04% 517
2023
Q1 		– Sell
-24,989
Closed -$487K – 1515
2022
Q4 		$487K Buy
+24,989
New +$494K ﹤0.01% 1280

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's MIRM Position: Q2 2026 in Review

Voloridge Investment Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 104,099 shares — an estimated $9.62M sold.

Voloridge Investment Management first reported a position in MIRM in Q4 2022 and held it in 10 quarters. The position peaked at $28.6M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Voloridge Investment Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 104,099 Mirum Pharmaceuticals shares in Q2 2026, an estimated $9.62M.
  • Voloridge Investment Management first reported a position in Mirum Pharmaceuticals in Q4 2022 and held it in 10 quarters.
  • Voloridge Investment Management's Mirum Pharmaceuticals position peaked at $28.6M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.